Here’s why Zip shares had a 10% dead cat bounce on Tuesday
Nick Sundich, October 24, 2023
Zip shares had a 10% dead cat bounce on Tuesday. For those who are unaware, a dead cat bounce is a small, brief recovery in the price of a declining stock. Despite the gain today, they are down nearly half in the last year and down 97% from all time highs.

Zip (ASX:ZIP) share price chart, log scale (Source: TradingView)
Why Zip shares had a dead cat bounce
Zip released its results for the September quarter (1Q24) this morning and some investors seemed to like it. The company boasted that it recorded positive cash EBITDA for the period. It recorded 32% revenue growth to $204.4m, 11% transaction volume growth to $2.3bn and it boasted 6.1m active customers.
The company told investors US bad debts were below its target range and that it had signed several key merchants during the quarter including Amaysim, and R.M. Williams. And finally, it claimed to have a health balance sheet with the face value of its Convertible Notes reducing to $110.1m.
So back to $12 per share?
We wouldn’t think so. Afterpay was, and still is, a great company. But too many investors have sought to find another one like it and bought several other companies that have done very little in comparison to Afterpay (if anything).
There were some negative signs such as a decline in transactions and transaction volume in the ANZ market – 6.1% quarter-on-quarter and 9.6% year-on-year – as well as a fall in Active Customers across the globe. And even though bad debts are lower than a year ago, they rose from 1.84% to 1.99% in the past quarter. And this is not the first dead cat bounce we have seen out of this company either. Investors betting that it will return to 2021 highs (or perhaps even 2022 highs) should expect to be disappointed.
What are the Best stocks to invest in right now?
Check our buy/sell stock tips
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
6 Undervalued Lithium Stocks to Invest In
As the global push towards decarbonization accelerates, lithium has emerged as one of the most vital resources for a cleaner…
10 Best Solar Stocks to Buy in 2025
As the world shifts toward renewable energy, the solar industry has become a key driver of growth and innovation. Solar…
Artrya (ASX:AYA): Newly FDA 510(k) approved, and so its all systems go!
3 and a half years after listing and nearly 7 years after its founding, Artrya (ASX:AYA) achieved the aspiration of…